Cardiovascular Risk Reduction
Research activity is centred on cardiovascular disease prevention in people with high and very high cardiovascular risk, with interest in reducing the burden of major vascular events.
- Hypertension
- Ischemic stroke
- Intracerebral haemorrhage
- Transient ischemic attack
- Peripheral arterial disease
The clinical focus also includes prevention across complex vascular profiles where multiple cardiometabolic and cerebrovascular risks overlap.
Cardiac and Rhythm Disorders
Trial interest extends to conditions affecting cardiac function and rhythm stability, including patients with established heart failure and atrial fibrillation.
- Heart failure
- Atrial fibrillation
This area reflects attention to chronic cardiovascular complications that contribute to long-term morbidity in high-risk populations.
Metabolic and Uric Acid Disorders
Another key interest is the management of hyperuricemia alongside broader metabolic risk, particularly where elevated uric acid may coexist with vascular disease.
- Hyperuricemia
- Diabetes mellitus
The research landscape includes patients with overlapping metabolic syndrome-related features and cardiovascular vulnerability.
Long-COVID and Preventive Medicine
Clinical interest also covers long-COVID syndrome in the context of prevention for individuals with elevated cardiovascular risk, linking post-infectious symptoms with vascular health concerns.
- Long-COVID syndrome
- Preventive medicine
This area connects post-viral sequelae with ongoing monitoring of patients who already carry significant cardiovascular and metabolic risk factors.
